CTEP Branches and Offices
Site Search
Search results for: Buy Dapoxetine hcl 30mg www.RxLara.com Priligy 60 tablet For Premature Ejaculation OTC www.rxlara.com
The following word(s) are in the skip word list and have been omitted from your search: "for"
Note that you can not search for exact phrases beginning with a skipped word.
Note that you can not search for exact phrases beginning with a skipped word.
No results found containing all search terms. 97 results found containing some search terms.
10 pages of results.
... or refractory Age 18 years EA9152 Newly diagnosed, no Acute myeloid activating FLT3 Age 60 years A041701 leukemia (AML) mutation Age 60 years, Precursor B- Newly ...
... ETCTN- Myeloma https:/clinicaltrials.gov/ct2/show /NCT03798678 Expansion Trial of a Novel wide Glutaminase Inhibitor (CB-839 HCl) in Combination with Carfilzomib and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma 10220 A ...
... ETCTN- Myeloma https:/clinicaltrials.gov/ct2/show /NCT03798678 Expansion Trial of a Novel wide Glutaminase Inhibitor (CB-839 HCl) in Combination with Carfilzomib and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma 10220 A ...
4. ST mutations
... Response 10220: A Phase II Basket Trial of Glutaminase Inhibitor (BeGIN) CB-839 HCl in Patients with NF1 Aberrations, NF1 NF1, KEAP1, and LKB1 Mutant Malignant ...
5. ST mutations
... Response 10220: A Phase II Basket Trial of Glutaminase Inhibitor (BeGIN) CB-839 HCl in Patients with NF1 Aberrations, NF1 NF1, KEAP1, and LKB1 Mutant Malignant ...
6. Myeloma
... 10219: Phase I Dose-Escalation and Dose-Expansion Trial of a Novel Glutaminase Inhibitor (CB-839 HCl) in Combination with Carfilzomib and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma 10076: ...
7. Myeloma
... 10219: Phase I Dose-Escalation and Dose-Expansion Trial of a Novel Glutaminase Inhibitor (CB-839 HCl) in Combination with Carfilzomib and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma 10076: ...
8. Lung
... Advanced NSCLC 10327: A Phase I Trial of MLN0128(TAK-228) and CB-839 HCL (telaglenastat) in Advanced NSCLC Patients Non -small cell lung cancer( NSCLC) ...
9. Lung
... Advanced NSCLC 10327: A Phase I Trial of MLN0128(TAK-228) and CB-839 HCL (telaglenastat) in Advanced NSCLC Patients Non -small cell lung cancer( NSCLC) ...
10. Brain
... Meningioma 10220: A Phase II Basket Trial of Glutaminase Inhibitor (BeGIN) CB-839 HCl in Patients with NF1 Aberrations, NF1 Peripheral nerve sheath tumors Peripheral nerve sheath tumors ...